BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

72 related articles for article (PubMed ID: 15714210)

  • 1. Comparison of 1- and 2-year screening intervals for women undergoing screening mammography.
    Wai ES; D'yachkova Y; Olivotto IA; Tyldesley S; Phillips N; Warren LJ; Coldman AJ
    Br J Cancer; 2005 Mar; 92(5):961-6. PubMed ID: 15714210
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cumulative Advanced Breast Cancer Risk Prediction Model Developed in a Screening Mammography Population.
    Kerlikowske K; Chen S; Golmakani MK; Sprague BL; Tice JA; Tosteson ANA; Rauscher GH; Henderson LM; Buist DSM; Lee JM; Gard CC; Miglioretti DL
    J Natl Cancer Inst; 2022 May; 114(5):676-685. PubMed ID: 35026019
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Long-term trends in incidence, characteristics and prognosis of screen-detected and interval cancers in women participating in the Dutch breast cancer screening programme.
    Ten Velde DE; Duijm LEM; van der Sangen MJC; Schipper RJ; Tjan-Heijnen VCG; Vreuls W; Strobbe LJA; Voogd AC
    Br J Cancer; 2024 May; 130(9):1561-1570. PubMed ID: 38467826
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Mammography Screening Among the Elderly: A Research Challenge.
    Sanderson M; Levine RS; Fadden MK; Kilbourne B; Pisu M; Cain V; Husaini BA; Langston M; Gittner L; Zoorob R; Rust GS; Hennekens CH
    Am J Med; 2015 Dec; 128(12):1362.e7-14. PubMed ID: 26169884
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effect of Breast Screening Regimen on Breast Cancer Outcomes: A Modeling Study.
    Yaffe MJ; Mainprize JG
    Curr Oncol; 2023 Oct; 30(11):9475-9483. PubMed ID: 37999106
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Estimate of overdiagnosis of breast cancer due to mammography after adjustment for lead time. A service screening study in Italy.
    Paci E; Miccinesi G; Puliti D; Baldazzi P; De Lisi V; Falcini F; Cirilli C; Ferretti S; Mangone L; Finarelli AC; Rosso S; Segnan N; Stracci F; Traina A; Tumino R; Zorzi M
    Breast Cancer Res; 2006; 8(6):R68. PubMed ID: 17147789
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Explaining the difference in prognosis between screen-detected and symptomatic breast cancers.
    Allgood PC; Duffy SW; Kearins O; O'Sullivan E; Tappenden N; Wallis MG; Lawrence G
    Br J Cancer; 2011 May; 104(11):1680-5. PubMed ID: 21540862
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Impact of Mammography Screening Frequency on Breast Cancer Mortality Rates.
    Abu Abeelh E; AbuAbeileh Z
    Cureus; 2023 Nov; 15(11):e49066. PubMed ID: 38125213
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Increased breast cancer mortality due to treatment delay and needle biopsy type: a retrospective analysis of SEER-medicare.
    Pathak R; Leslie M; Dondapati P; Davis R; Tanaka K; Jett E; Chervoneva I; Tanaka T
    Breast Cancer; 2023 Jul; 30(4):627-636. PubMed ID: 37130988
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Considerations for Evaluating the Introduction of New Cancer Screening Technology: Use of Interval Cancers to Assess Potential Benefits and Harms.
    Farber R; Houssami N; Barnes I; McGeechan K; Barratt A; Bell KJL
    Int J Environ Res Public Health; 2022 Nov; 19(22):. PubMed ID: 36429373
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Annual vs Biennial Screening: Diagnostic Accuracy Among Concurrent Cohorts Within the Ontario Breast Screening Program.
    Chiarelli AM; Blackmore KM; Mirea L; Done SJ; Majpruz V; Weerasinghe A; Rabeneck L; Muradali D
    J Natl Cancer Inst; 2020 Apr; 112(4):400-409. PubMed ID: 31233138
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Annual mammography at age 45-49 years and biennial mammography at age 50-69 years: comparing performance measures in an organised screening setting.
    Bucchi L; Ravaioli A; Baldacchini F; Giuliani O; Mancini S; Vattiato R; Falcini F; Giorgi Rossi P; Campari C; Canuti D; Di Felice E; Sassoli de Bianchi P; Ferretti S; Bertozzi N;
    Eur Radiol; 2019 Oct; 29(10):5517-5527. PubMed ID: 30887204
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Estimating breast cancer mortality reduction and overdiagnosis due to screening for different strategies in the United Kingdom.
    Gunsoy NB; Garcia-Closas M; Moss SM
    Br J Cancer; 2014 May; 110(10):2412-9. PubMed ID: 24762956
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Breast cancer survival and prognosis by screening history.
    Coldman AJ; Phillips N
    Br J Cancer; 2014 Feb; 110(3):556-9. PubMed ID: 24300976
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Mammographic screening interval in relation to tumor characteristics and false-positive risk by race/ethnicity and age.
    O'Meara ES; Zhu W; Hubbard RA; Braithwaite D; Kerlikowske K; Dittus KL; Geller B; Wernli KJ; Miglioretti DL
    Cancer; 2013 Nov; 119(22):3959-67. PubMed ID: 24037812
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Outcomes of screening mammography by frequency, breast density, and postmenopausal hormone therapy.
    Kerlikowske K; Zhu W; Hubbard RA; Geller B; Dittus K; Braithwaite D; Wernli KJ; Miglioretti DL; O'Meara ES;
    JAMA Intern Med; 2013 May; 173(9):807-16. PubMed ID: 23552817
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Breast cancer screening: review of benefits and harms, and recommendations for developing and low-income countries.
    Al-Foheidi M; Al-Mansour MM; Ibrahim EM
    Med Oncol; 2013 Jun; 30(2):471. PubMed ID: 23420062
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Tipping the balance of benefits and harms to favor screening mammography starting at age 40 years: a comparative modeling study of risk.
    van Ravesteyn NT; Miglioretti DL; Stout NK; Lee SJ; Schechter CB; Buist DS; Huang H; Heijnsdijk EA; Trentham-Dietz A; Alagoz O; Near AM; Kerlikowske K; Nelson HD; Mandelblatt JS; de Koning HJ
    Ann Intern Med; 2012 May; 156(9):609-17. PubMed ID: 22547470
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Impact of intermediate mammography assessment on the likelihood of false-positive results in breast cancer screening programmes.
    Ascunce N; Ederra M; Delfrade J; Baroja A; Erdozain N; Zubizarreta R; Salas D; Castells X;
    Eur Radiol; 2012 Feb; 22(2):331-40. PubMed ID: 21901564
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Prediction of higher mortality reduction for the UK Breast Screening Frequency Trial: a model-based approach on screening intervals.
    van Ravesteyn NT; Heijnsdijk EA; Draisma G; de Koning HJ
    Br J Cancer; 2011 Sep; 105(7):1082-8. PubMed ID: 21863031
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.